TEDCO CEO George Davis has spent several months in his new role traveling the state and talking to startups and other tech industry players, trying to figure out how his organization can best serve Maryland’s entrepreneurial community beyond what it has been doing for the past 20 years.
May 15 & 16, 2018 – Hyatt Regency San Francisco Airport
The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA), and Center for Devices and Radiological Health (CDRH) Division of Industry and Consumer Education (DICE) are pleased to announce a co-sponsored event developed just for you.
Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leader in the field of antibody-drug conjugates (ADCs), today announced the appointment of Robert Iannone, M.D., M.S.C.E., as Head of Research & Development and Chief Medical Officer, effective today. In his new role, Dr. Iannone will oversee and lead all clinical development, regulatory, pre-clinical, translational research and medical affairs strategies and activities of the Company. Dr. Iannone brings more than thirteen years of experience in clinical drug development, including the approval of several targeted and immuno-oncology medicines at AstraZeneca/MedImmune and Merck & Co.
The 2018 Maryland Incubator Company of the Year Awards publicly recognizes achievements by current clients and graduates of Maryland incubators and provides a forum for the nominees to increase their visibility in the business, technology and investment communities.
Business incubators support new and early-stage businesses in Maryland. In 1986, the first public incubator was established at the University of Maryland in College Park. Recognizing the economic challenges facing new companies, business incubators are facilities that provide reasonable market rents, shared services and technical assistance to start-ups and early-stage companies, including manufacturing, biotech, service and technology firms.
An aerospace company born out of the University of Maryland, College Park has raised $1.45 million in a round led by the University System of Maryland and the Abell Foundation.
Funding has been flowing into biotech over the past few years.
Over one week earlier this year, biotech and healthcare startups raised almost $1 billion in capital. And on Tuesday, a cancer-drug startup called Allogene raised $300 million in its series A round.
Accelerate tech product development with MIPS funding.
The Maryland Industrial Partnerships (MIPS) program provides funding for university research projects that help companies develop new technology products.
In reviewing data regarding the hundreds of TBED-related investment funds, SSTI found that 24 of them have invested in at least one dozen startups each over the past year. The funds are characterized as economic development, university-centric, regionally focused, or impact oriented investment funds, incubators and accelerator programs located in the U.S. or Canada. Data the various funds provide to Pitchbook is the source of the list below, ranked in order by activity level. Each organization may have used their public or university funding to support operations, due diligence or mentoring of portfolio companies and/or to support direct invest into startups. University-centered activities in the list are denoted by an asterisk at the end of the entry. Two of the most active 24 funds are nonprofit, impact accelerators supported in part by foundations and corporation philanthropy.
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces receipt of a letter from the Center for Drug Evaluation (CDE) (group within the China FDA in charge of technical review) indicating that EVOMELA® (melphalan) for injection has been scheduled for review by the Expert Advisory Anti-Tumor (Oncology) Drugs Committee (the “Advisory Committee”), which is scheduled to take place between April 25-26, 2018 (the “Advisory Committee Meeting”).
Deadline to apply is April 17, 2018
The Maryland Tech Council and SoBran are celebrating the transformational science coming out of Maryland and surrounding area by establishing the Innovation for Impact Prize. This is an added annual award at the Industry Awards Celebration. Tell us how your innovative research will impact the world one day and describe your research!
